STAT

Opinion: The crusade for ‘religious liberty’ will reverberate badly in health care

Supreme Court nominee Judge Brett Kavanaugh looks over notes as he testifies before the Senate Judiciary Committee on the third day of his confirmation hearing on Capitol Hill.

Not that long ago, there was little difference between a physician and a preacher, a clinic and a chapel, a patient and a proselyte. Instead of prescribing medications, healers chanted hymns; instead of prescribing painkillers, they offered prayers.

Faith remains an integral part of human society and the modern hospital is a place where patients and physicians of all faiths work together. I am a Muslim physician who trained at a Boston hospital formed because none of the other local hospitals would offer Jewish doctors a job. On any given day, I see patients from myriad faiths, not to mention cultural backgrounds and sexual orientations.

I worry that the Trump administration is turning that directs federal agencies to give individuals and organizations great freedom to act — or refuse action — if they believe it impinges on their freedom of religious expression. This builds on the Department of Health and Human Services creating a , making it easier for doctors and nurses to refuse to treat patients based on religious or cultural objections.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related